Agenus to provide second quarter 2023 financial report and corporate update

Lexington, mass.--(business wire)--immuno-oncology leader, agenus (nasdaq: agen), today announced the company will release its second quarter 2023 financial results via press release before the market opens on tuesday, august 8, 2023. in addition, dr. garo armen, chairman and ceo of agenus, will participate in the following upcoming investor conferences: btig virtual biotechnology conference 2023 – fireside chat presentation will be held virtually on monday, august 7th, 2023 at 3:00 pm et. a re.
AGEN Ratings Summary
AGEN Quant Ranking